5-HT2 receptors-mediated modulation of voltage-gated K + channels and neurophysiopathological correlates

Experimental Brain Research

Volumn 230, Issue 4, 2013, Pages 453-462

  D'Adamo, Maria Cristina ^a,b   Servettini, Ilenio ^a,b   Guglielmi, Luca ^a   Di Matteo, Vincenzo ^c   Di Maio, Roberto ^d,e   Di Giovanni, Giuseppe ^b,f,g   Pessia, Mauro ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IEMEST   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e RiMED Foundation   (Italy)

^f UNIVERSITY OF MALTA   (Malta)

^g CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5 HT2A; 5 HT2C; Cortical pyramidal neuron; Kinase; Kv1.1; Kv1.2; Phosphatase; RPTP ; Serotonin receptor; Tyrosine phosphorylation

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CALCIUM ION; CANNABINOID; COCAINE; CORTICOTROPIN; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; HYDROCORTISONE; LYSERGIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM ION; PROLACTIN; PROTEIN TYROSINE KINASE; PSYCHEDELIC AGENT; RENIN; SEROTONIN; SEROTONIN 2 AGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNINDEXED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; ATAXIA; BRAIN CORTEX; COCAINE DEPENDENCE; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG TARGETING; HALLUCINATION; HUMAN; IMAGE ANALYSIS; LIMBIC SYSTEM; NERVE CELL CULTURE; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SEIZURE; SEROTONINERGIC SYSTEM; TARDIVE DYSKINESIA; ANIMAL; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; NEURONS; PHOSPHORYLATION; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84885651222     PISSN: 00144819     EISSN: 14321106     Source Type: Journal    
DOI: 10.1007/s00221-013-3555-8     Document Type: Article

References (67)

1. Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599
2. Aiyar J, Grissmer S, Chandy KG (1993) Full-length and truncated Kv1.3 K+ channels are modulated by 5-HT1c receptor activation and independently by PKC. Am J Physiol 265:C1571-C1578
3. + channel from human T lymphocytes. FEBS Lett 303(2-3):229-232
4. Boland LM, Jackson KA (1999) Protein kinase C inhibits Kv1.1 potassium channel function. Am J Physiol 277:C100-C110
5. Bowlby MR, Fadool DA, Holmes TC, Levitan I (1997) Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases. J Gen Physiol 110:601-610
6. 2C receptors in the ventral tegmental area. Neuroscience 146(1):286-297
7. Canchero TG, Morielli AD, Peralta EG (1998) The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel. Cell 93:1077-1085
8. Chandy KG, Gutman GA (1993) Nomenclature for mammalian potassium channel genes. Trends Pharmacol Sci 14(12):434
9. 2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol 73:748-757
10. + currents in pulmonary artery smooth muscle cells. Circ Res 98:931-938
11. Colino A, Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328:73-77
12. D'Adamo MC, Liu Z, Adelman JP, Maylie J, Pessia M (1998) Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J 17:1200-1207
13. D'Adamo MC, Imbrici P, Sponcichetti F, Pessia M (1999) Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function. FASEB J 13:1335-1345
14. D'Adamo MC, Hanna MG, Di Giovanni G, Pessia M (2012) Episodic ataxia type 1. In: Pagon RA, Bird TC, Dolan CR, Stephens K (eds) Genereviews. University of Washington, Seattle (WA) [Internet]
15. D'Adamo MC, Di Giovanni G, Pessia M (2013) Animal models of episodic ataxia type 1 (EA1). In: LeDoux MS (ed) Movement disorders: genetics and models, 2nd edn. Elsevier, Amsterdam
16. 2+ responses in rat primary astrocyte cultures. J Neurosci Res 35:246-256
17. Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E (2006) Central serotonin2c receptor: from physiology to pathology. Curr Top Med Chem 6:1909-1925
18. Di Giovanni G, Esposito E, Di Matteo V (eds) (2011) 5-HT2C receptors in the pathophysiology of CNS disease. Springer, New York
19. Di Matteo V, Di Giovanni G, Esposito E (2000) SB 242084: a selective 5-HT(2C) receptor antagonist. CNS Drugs Rev 3:195-205
20. + conduction and selectivity. Science 280(5360):69-77
21. + channels by protein-tyrosine phosphatase ε tunes neuronal excitability. J Biol Chem 287(33):27614-27628
22. Fadool DA, Holmes TC, Berman K, Dagan D, Levitan IB (1997) Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel. J Neurophysiol 78:1563-1573
23. Felsch JS, Cachero TG, Peralta EG (1998) Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor. Proc Natl Acad Sci USA 95:5051-5056
24. Guillemare E, Honoré E, Pradier L, Lesage F, Schweitz H, Attali B, Barhanin J, Lazdunski M (1992) Effects of the level of mRNA expression on biophysical properties, sensitivity to neurotoxins, and regulation of the brain delayed-rectifier K+ channels Kv1 2. Biochemistry 31(49):12463-12468
25. Gundlah C, Pecins-Thompson M, Schutzer WE, Bethea CL (1999) Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 63(2):325-339
26. Harvey AL, Karlsson E (1980) Dendrotoxin from the venom of the green mamba, dendroaspis angusticeps. A neurotoxin that enhances acetylcholine release at neuromuscular junction. Naunyn Schmiedebergs. Arch Pharmacol 312(1):1-6
27. Hermle L, Gouzoulis-Mayfrank E, Spitzer M (1998) Blood flow and cerebral laterality in the mescaline model of psychosis. Pharmacopsychiatry 31(2):85-91
28. Hille B (2001) Ionic channels of excitable membranes. Sinauer, Sunderland (MA)
29. 1C receptor mRNA in adult rat brain. FEBS Lett 247:453-462
30. Hoger JH, Walter AE, Vance D, Yu L, Lester HA, Davidson N (1991) Modulation of a cloned mouse brain potassium channel. Neuron 6:227-236
31. Holmes TC, Fadool DA, Ren R, Levitan IB (1996) Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain. Science 274:2089-2091
32. + channels by serotonin. Brain Res 617:285-295
33. Imbrici P, Tucker SJ, D'Adamo MC, Pessia M (2000) Role of RPTPα and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels. Pflügers Archiv-Eur J Physiol 441:257-262
34. Isacoff EY et al (1990) Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes. Nature 345:530-534
35. 2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12:324-329
36. + channel. Nature 423:33-41
37. + channel. Nature 423:42-48
38. + channels expressed in Xenopus oocytes. Biochem J 277:899-902
39. Klein L, Hopkins J (1981) Behavioral and cardiorespiratory responses to 4-aminopyridine in healthy awake horses. Am J Vet Res 42(9):1655-1657
40. Lambe EK, Aghajanian GK (2001) The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci 21(24):9955-9963
41. Lambe EK, Goldman-Rakic PS, Aghajanian GK (2000) Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cereb Cortex 10(10):974-980
42. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745
43. 2c receptor isoforms. J Biol Chem 279:2945-2954
44. Meller R, Harrison PJ, Sharp T (2002) Studies on the role of calcium in the 5-HT-stimulated release of glutamate from C6 glioma cells. Eur J Pharmacol 445(1-2):13-19
45. Millan MJ, Marin P, Bockaert J, Mannoury la Cour C (2008) Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 29:454-464
46. 1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86:6793-6797
47. Moran O, Dascal N, Lotan I (1991) Modulation of a shaker potassium A-channel by protein kinase C activation. FEBS Lett 279:256-260
48. Oberndorfer S, Saletu-Zyhlarz G, Saletu B (2000) Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology 42(2):69-81
49. + channel expressed in Xenopus oocytes. FEBS Lett 381:71-76
50. Pessia M, Jiang ZG, North RA, Johnson SW (1994) Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 654(2.2):324-330
51. Petrone A, Battaglia F, Wang C, Dusa A, Su J, Zagzag D, Bianchi R, Casaccia-Bonnefil P, Arancio O, Sap J (2003) Receptor protein tyrosine phosphatase alpha is essential for hippocampal neuronal migration and long-term potentiation. EMBO J 22(16):4121-4131
52. Ruppersberg JP et al (1990) Heteromultimeric channels formed by rat brain potassium-channel proteins. Nature 345:535-537
53. 1C receptor subtypes. Biochem Biophys Res Commun 181:1469-1478
54. Sap J, D'Eustachio P, Givol D, Schlessinger J (1990) Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Nat Acad Sci USA 87(16):6112-6116
55. + channel subunit in different neurons of rat brain. J Neurosci 14:2408-2417
56. Sia RL, Boonstra S, Westra P, Haenen HT, Wesseling H (1982) An electroencephalographic study of 4-aminopyridine. Anesth Analg 61(4):354-357
57. Silveira R, Siciliano J, Abo V, Viera L, Dajas F (1988) Intrastriatal dendrotoxin injection: behavioral and neurochemical effects. Toxicon 26(11):1009-1015
58. Speake T, Kibble JD, Brown PD (2004) Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying K+ conductance in rat choroid plexus epithelial cells. Am J Physiol Cell Physiol 286(3):C611-C620
59. Tempel BL, Papazian DM, Schwarz TL, Jan YN, Jan LY (1987) Sequence of a probable potassium channel component encoded at shaker locus of Drosophila. Science 237(4816):770-775
60. 2+-dependent release of glutamate from guinea-pig cerebrocortical synaptosomes. J Neurochem 52:201-206
61. Tibbs GR, Dolly JO, Nicholls DG (1996) Evidence for the induction of repetitive action potentials in synaptosomes by K-channel inhibitors: an analysis of plasma membrane ion fluxes. J Neurochem 67:389-397
62. Trimmer JS, Rhodes KJ (2004) Localization of voltage-gated ion channels in mammalian brain. Annu Rev Physiol 66:477-519
63. Tsai W, Morielli AD, Cachero TG, Peralta EG (1999) Receptor protein tyrosine phosphatase alpha participates in the m1 muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity. EMBO J 18:109-118
64. Veh RW, Lichtinghagen R, Sewing S, Wunder F, Grumbach IM, Pongs O (1995) Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain. Eur J Neurosci 7:2189-2205
65. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16(5):357-372
66. + channels in terminal and juxtaparanodal regions of neurons. Nature 365:75-79
67. Wang H, Kunkel DD, Schwartzkroin PA, Tempel BL (1994) Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J Neurosci 14:4588-4599